SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder

The cannabis oil will be used as a part of the Company‘s proprietary SCI-210 treatment combination of CBD and CannAmide™  TEL AVIV, Israel, Feb. 27, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of  ... Read More

CBD Life Sciences : Financial Statement

CBD Lifesciences, Inc. Consolidated Balance Sheet As of March 31, 2022 (Unaudited) ASSETS CURRENT ASSETS: Cash $ 303,093 Inventory 9,269 Due from a related party 120,426 Total current assets … Original Author Link click here to read complete story.. ... Read More